[Laboratory and clinical studies on amikacin (BB-K8), a new semisynthetic aminoglycoside (author's transl)].
D000328:Adult; D000368:Aged; D000613:Aminobutyrates / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D002675:Child, Preschool; D003556:Cystitis / Q000188:drug therapy; D004926:Escherichia coli / Q000187:drug effects; D005260:Female; D006801:Humans; D007612:Kanamycin / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D007711:Klebsiella pneumoniae / Q000187:drug effects; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D011470:Prostatic Hyperplasia / Q000188:drug therapy; D011514:Proteus vulgaris / Q000187:drug effects; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D011704:Pyelonephritis / Q000188:drug therapy; D013530:Surgical Wound Infection / Q000517:prevention & control; D014552:Urinary Tract Infections / Q000188:drug therapy
D000613:Aminobutyrates; D007612:Kanamycin